The Saul R. Korey Department of Neurology created a visionary model of neurological care that enabled us to envision neurological diseases as lifespan disorders, forever changing the lens through which neurological diseases are understood. 

Childhood and early onset disorders necessitate different treatment modalities as the brain changes during adult life and aging. As medical breakthroughs have increased the median survival, our institution offers a destination site reflecting the aspiration that these patients can lead increasingly productive and fulfilling lives as they age. Research carried out in departmental laboratories has led to the paradigm-shifting discovery that aging likely starts at conception, and that the forerunners of late-onset dementias had their origin at the early stages of life, and account for the fact that these disorders in fact are systemic disorders that need to be treated in an interdisciplinary way. These revolutionary discoveries have profound implications for the early treatment of these currently untreatable conditions using a range of stem cell, epigenetic reprogramming and dynamic tissue remodeling strategies, thereby offering hope for the development of true disease-modifying treatments and even disease cures.

Creating Transformative Solutions to the
Intractable Challenges of Neurologic Disease

A premiere example of our global leadership, interdisciplinary collaborations, and commitment to the interdependence of neurologic disease, multigenerational inheritance, community integration and environmental contingencies is our recognition in innovative approaches to stroke research and clinical care.

Montefiore Einstein is spearheading and participating in numerous clinical trials to advance promising interventions for stroke prevention, treatment, recovery and rehabilitation for patients with or at risk of a stroke across all stages of life. We are a founding partner and key member of the New York City Collaborative Regional Coordinating Center (NYCC-RCC), the largest National Institutes of Health (NIH)-funded multi-institutional consortium dedicated to stroke prevention, treatment, education and rehabilitation efforts to reduce the burden of stroke on children and adults throughout the country. Distinguished as an inaugural NIH StrokeNet Regional Coordinating Center since the inception of this highly competitive NIH initiative (StrokeNet) in 2013, we are among an elite group of only 27 centers in the nation to be awarded a five-year grant funded by the National Institute of Neurological Disorders and Stroke (NINDS).